04/15/2024
3:38 PM | Contineum Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
04/15/2024
3:20 PM | Contineum Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
04/11/2024
5:10 PM | Contineum Therapeutics (Issuer)
Versant Side Fund IV, L.P. (Reporting)
Versant Vantage I GP, L.P. (Reporting)
Versant Vantage I GP-GP, LLC (Reporting)
Versant Vantage I, L.P. (Reporting)
Versant Venture Capital IV, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Ventures IV, LLC (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
4:05 PM | Contineum Therapeutics (Issuer)
JOHNSON & JOHNSON (Reporting)
Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/10/2024
4:12 PM | Contineum Therapeutics (Subject)
JOHNSON & JOHNSON (Filed by)
| Form SC 13G | |
04/09/2024
3:49 PM | Contineum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
3:47 PM | Contineum Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/05/2024
6:08 PM | Contineum Therapeutics (Filer)
| Form 424B4 | |
04/04/2024
11:14 PM | Contineum Therapeutics (Filer)
| Form EFFECT | |
04/04/2024
8:22 PM | Contineum Therapeutics (Issuer)
Versant Side Fund IV, L.P. (Reporting)
Versant Vantage I GP, L.P. (Reporting)
Versant Vantage I GP-GP, LLC (Reporting)
Versant Vantage I, L.P. (Reporting)
Versant Venture Capital IV, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Ventures IV, LLC (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:49 PM | Contineum Therapeutics (Issuer)
Stengone Carmine N. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:51 PM | Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:52 PM | Contineum Therapeutics (Issuer)
Slover Peter T (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:54 PM | Contineum Therapeutics (Issuer)
Huhn Stephen L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:56 PM | Brady Todd R. (Reporting)
Contineum Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:58 PM | Contineum Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:59 PM | Contineum Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:59 PM | Contineum Therapeutics (Issuer)
Ware Olivia C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
1:09 PM | Contineum Therapeutics (Filer)
| Form CERT | |
04/01/2024
7:41 AM | Contineum Therapeutics (Filer)
| Form S-1/A | |
